Who is sponsoring NCT05478330?

NCT05478330 is sponsored by Zagazig University.

What drugs are being tested in NCT05478330?

Interventions in NCT05478330: Flutamide 1% gel, topical gel without flutamide.

What condition does NCT05478330 study?

NCT05478330 studies Acne Vulgaris Superficial Mixed Comedonal and Inflammatory.

Is NCT05478330 still recruiting?

NCT05478330 is currently completed. Last updated 28 July 2022.

Last reviewed 2022-07-28 · How we verify

NCT05478330

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne Vulgaris

Completed NA Last updated 28 July 2022

What this trial tests

NA trial testing Flutamide 1% gel in Acne Vulgaris Superficial Mixed Comedonal and Inflammatory in 50 participants. Completed in 30 June 2022.

Timeline

13 January 2021

Primary endpoint
30 June 2022

30 June 2022

Quick facts

Lead sponsor	Zagazig University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	50
Start date	13 January 2021
Primary completion	30 June 2022
Estimated completion	30 June 2022
Sites	1 location across Egypt

Drugs / interventions tested

Flutamide 1% gel — full drug profile →
topical gel without flutamide — full drug profile →

Conditions studied

Acne Vulgaris Superficial Mixed Comedonal and Inflammatory — all drugs for Acne Vulgaris Superficial Mixed Comedonal and Inflammatory →

Sponsor

Zagazig University

Who can join

Adults 16 to 40, any sex, with Acne Vulgaris Superficial Mixed Comedonal and Inflammatory. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

From the obtained results, topical Flutamide 1% gel can be a promising, effective, and safe alternative in treating patients with acne vulgaris with minimal side effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05478330 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 28 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05478330.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing